Skip to main content
 

Main menu

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Coming Next Month
    • Archives
    • Most-Read Papers of 2021
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2022 Call for Abstracts
    • 2021 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal

User menu

  • Subscribe
  • My alerts
  • Log in

Search

  • Advanced search
American Association for Respiratory Care
  • Subscribe
  • My alerts
  • Log in
American Association for Respiratory Care

Advanced Search

  • Home
  • Content
    • Current Issue
    • Editor's Commentary
    • Coming Next Month
    • Archives
    • Most-Read Papers of 2021
  • Authors
    • Author Guidelines
    • Submit a Manuscript
  • Reviewers
    • Reviewer Information
    • Create Reviewer Account
    • Reviewer Guidelines: Original Research
    • Reviewer Guidelines: Reviews
    • Appreciation of Reviewers
  • CRCE
    • Through the Journal
    • JournalCasts
    • AARC University
    • PowerPoint Template
  • Open Forum
    • 2022 Call for Abstracts
    • 2021 Abstracts
    • Previous Open Forums
  • Podcast
    • English
    • Español
    • Portugûes
    • 国语
  • Videos
    • Video Abstracts
    • Author Interviews
    • Highlighted Articles
    • The Journal
  • Twitter
  • Facebook
  • YouTube
Research ArticleOriginal Research

Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection

Anup K Singh, Margarita Oks, Gregg Husk, Samuel P Dechario, Bushra Mina, Kanwaljit Singh, Linda Kirschenbaum, Charles M Carpati, Omar Mahmoud, Nader Ishak Gabra, Oki Ishikawa, Erica Altschultz, Varun Shah, Akhilesh Mahajan, Arun Gautam, Brian Birnbaum, Anthony C Antonacci and Suhail Raoof
Respiratory Care December 2021, 66 (12) 1805-1814; DOI: https://doi.org/10.4187/respcare.08779
Anup K Singh
Department of Pulmonary Critical Care and Sleep Medicine, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Margarita Oks
Department of Pulmonary Critical Care and Sleep Medicine, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregg Husk
Hospital Administration, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel P Dechario
Department of Surgery, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bushra Mina
Department of Pulmonary Critical Care and Sleep Medicine, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kanwaljit Singh
Critical Path Institute – International Neonatal Consortium, Tucson, Arizona.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Linda Kirschenbaum
Department of Pulmonary Critical Care and Sleep Medicine, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Charles M Carpati
Department of Pulmonary Critical Care and Sleep Medicine, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Omar Mahmoud
Department of Pulmonary Critical Care and Sleep Medicine, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nader Ishak Gabra
Department of Pulmonary Critical Care and Sleep Medicine, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Oki Ishikawa
Department of Pulmonary Critical Care and Sleep Medicine, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erica Altschultz
Department of Pulmonary Critical Care and Sleep Medicine, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Varun Shah
Department of Pulmonary Critical Care and Sleep Medicine, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Akhilesh Mahajan
Department of Pulmonary Critical Care and Sleep Medicine, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arun Gautam
Department of Pulmonary Critical Care and Sleep Medicine, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian Birnbaum
Department of Pulmonary Critical Care and Sleep Medicine, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anthony C Antonacci
Department of Surgery, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suhail Raoof
Department of Pulmonary Critical Care and Sleep Medicine, Lenox Hill Hospital – Northwell Health System, New York, New York.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    World Health Organization. 2021. WHO Coronavirus (COVID-19) Dashboard, May 30, 2021, https://covid19.who.int. Accessed May 30, 2021.
  2. 2.↵
    1. Soy M,
    2. Keser G,
    3. Atagündüz P,
    4. Tabak F,
    5. Atagündüz I,
    6. Kayhan S
    . Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol 2020;39(7):2085-2094.
    OpenUrlPubMed
  3. 3.↵
    1. Tajbakhsh A,
    2. Gheibi Hayat SM,
    3. Taghizadeh H,
    4. Akbari A,
    5. Inabadi M,
    6. Savardashtaki A,
    7. et al
    . COVID-19 adn cardiac injury: clinical manifestations biomarkers, mechanisms, diagnosis, treatment, and follow up. Expert Rev Anti Infect Ther 2021;19(3):345-357.
    OpenUrl
  4. 4.↵
    1. Petrilli CM,
    2. Jones SA,
    3. Yang J,
    4. Rajagopalan H,
    5. O’Donnell L,
    6. Chernyak Y,
    7. et al
    . Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 2020;369:m1966.
    OpenUrlAbstract/FREE Full Text
  5. 5.↵
    1. Yang K,
    2. Sheng Y,
    3. Huang C,
    4. Jin Y,
    5. Xiong N,
    6. Jiang K,
    7. et al
    . Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol 2020;21(7):904-913.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Rottoli M,
    2. Bernante P,
    3. Belvedere A,
    4. Garelli S,
    5. Giannella M,
    6. et al
    . How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre. Eur J Endocrinol 2020;183(4):389-397.
    OpenUrlPubMed
  7. 7.
    1. Simonnet A,
    2. Chetboun M,
    3. Poissy J,
    4. Raverdy V,
    5. Noulette J,
    6. Duhamel A,
    7. et al
    . High prevalence of obesity in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) requiring invasive mechanical ventilation. Obesity (Silver Spring) 2020;28(7):1195-1199.
    OpenUrl
  8. 8.↵
    1. Palaiodimos L,
    2. Kokkinidis DG,
    3. Li W,
    4. Karamanis D,
    5. Ognibene J,
    6. Arora S,
    7. et al
    . Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism 2020;108:154262.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Goyal P,
    2. Choi JJ,
    3. Pinheiro LC,
    4. Schenck EJ,
    5. Chen R,
    6. Jabri A,
    7. et al
    . Clinical characteristics of Covid-19 in New York City. N Engl J Med 2020;382(24):2372-2374.
  10. 10.↵
    1. Price CC,
    2. Altice FL,
    3. Shyr Y,
    4. Koff A,
    5. Pischel L,
    6. Goshua G,
    7. et al
    . Tocilizumab treatment for cytokine release syndrome in hospitalized patient with coronavirus disease 2019: survival and clinical outcomes. CHEST 2020;158(4):1397-1408.
    OpenUrl
  11. 11.↵
    1. Sinha P,
    2. Mostaghim A,
    3. Bielick CG,
    4. McLaughlin A,
    5. Hamer DH,
    6. Wetzler LM,
    7. et al
    . Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis 2020;99:28-33.
    OpenUrlCrossRefPubMed
  12. 12.↵
    1. Gupta S,
    2. Wang W,
    3. Hayek SS,
    4. Chan L,
    5. Mathews KS,
    6. Melamed ML,
    7. et al
    . Association between early treatment with tocilizumab and mortality among critically ill patients with COVID-19. JAMA Intern Med 2021;181(1):41-51.
    OpenUrl
  13. 13.↵
    1. Potere N,
    2. Di Nisio M,
    3. Cibelli D,
    4. Scurti R,
    5. Frattari A,
    6. Porreca E,
    7. et al
    . Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case–control study. Ann Rheum Dis 2021;80(2):1-2.
    OpenUrlFREE Full Text
  14. 14.
    1. Canziani LM,
    2. Trovati S,
    3. Brunetta E,
    4. Testa A,
    5. De Santis M,
    6. Bombardieri E,
    7. et al
    . Interleukin-6 receptor blocking with intravenous tocilizumab in COVID-19 severe acute respiratory distress syndrome: a retrospective case-control survival analysis of 128 patients. J Autoimmun 2020;114:102511.
    OpenUrlCrossRefPubMed
  15. 15.↵
    1. Campochiaro C,
    2. Della-Torre E,
    3. Cavalli G, De Luca G, Ripa M, Boffini,
    4. et al
    . Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study. Eur J Intern Med 2020;76:43-49.
    OpenUrlCrossRefPubMed
  16. 16.↵
    1. Jiménez-Brítez G,
    2. Ruiz P,
    3. Soler X
    . Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience. Med Clin (Barc) 2020;155(9):409-411.
    OpenUrl
  17. 17.↵
    1. Rosas IO,
    2. Brau N,
    3. Waters M,
    4. Go RC,
    5. Hunter BD,
    6. Bhagani S,
    7. et al
    . Tocilizumab in hospitalized patients with COVID-19 pneumonia. N Engl J Med 2021;348(16):1503-1516.
    OpenUrl
  18. 18.↵
    1. Stone JH,
    2. Frigault MJ,
    3. Serling-Boyd NJ,
    4. Fernandes AD,
    5. Harvey L,
    6. Foulkes AS,
    7. et al
    . Efficacy of Tocilizumab in patients hospitalized with Covid-19. N Engl J Med 2020;383(24):2333-2344.
    OpenUrlCrossRefPubMed
  19. 19.↵
    1. Salvarani C,
    2. Dolci G,
    3. Massari M,
    4. Merlo DF,
    5. Cavuto S,
    6. Savoldi L,
    7. et al
    . Effect of tocilizumab vs standard care on clinical worsening in patients hospitalized with COVID-19 pneumonia: a randomized clinical trial. JAMA Intern Med 2021;181(1):24-31.
    OpenUrl
  20. 20.↵
    1. Hermine O,
    2. Mariette X,
    3. Tharaux P-L,
    4. Resche-Rigon M,
    5. Porcher R,
    6. Ravaud P
    , CORIMUNO-19 Collaborative Group. Effect of tocilizumab vs usual care in adults hospitalized with COVID-19 and moderate or severe pneumonia: a randomized clinical trial. JAMA Intern Med 2021;181(1):32-40.
    OpenUrl
  21. 21.↵
    1. Horby P,
    2. Lim WS,
    3. Emberson JR,
    4. Mafham M,
    5. Bell JL,
    6. et al
    RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with Covid-19. N Engl J Med 2021;384(8):693-704.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Sterne JAC,
    2. Murthy S,
    3. Diaz JV,
    4. Slutsky AS,
    5. Villar J,
    6. et al
    WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group; Sterne JAC, Murthy S, Diaz JV, Slutsky AS, Villar J, et al. Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis. JAMA 2020;324(13):1330-1341.
    OpenUrlCrossRefPubMed
  23. 23.↵
    1. Ramiro S,
    2. Mostard RLM,
    3. Magro-Checa C,
    4. van Dongen CMP,
    5. Dormans T,
    6. Buijs J,
    7. et al
    . Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study. Ann Rheum Dis 2020;79(9):1143-1151.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 2021;397(10285):1637-1645. May 1
    OpenUrlPubMed
  25. 25.↵
    1. Zhang X,
    2. Tan Y,
    3. Ling Y,
    4. Lu G,
    5. Liu F,
    6. Yi Z,
    7. et al
    . Viral and host factors related to the clinical outcome of COVID-19. Nature 2020;583(7816):437-440.
    OpenUrlCrossRefPubMed
  26. 26.↵
    1. Su H,
    2. Yang M,
    3. Wan C,
    4. Yi L-X,
    5. Tang F,
    6. Zhu H-Y,
    7. et al
    . Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China. Kidney Int 2020;98(1):219-227.
    OpenUrlCrossRefPubMed
  27. 27.↵
    1. Wang G,
    2. Wu C,
    3. Zhang Q,
    4. Wu F,
    5. Yu B,
    6. Lv J,
    7. et al
    . C-reactive protein level may predict the risk of COVID-19 aggravation. Open Forum Infect Dis 2020;7(5):ofaa153.
    OpenUrlCrossRefPubMed
  28. 28.↵
    1. Sahu BR,
    2. Kampa RK,
    3. Padhi A,
    4. Panda AK
    . C-reactive protein: a promising biomarker for poor prognosis in COVID-19 infection. Clin Chim Acta 2020;509(509):91-94.
    OpenUrlPubMed
PreviousNext
Back to top

In this issue

Respiratory Care: 66 (12)
Respiratory Care
Vol. 66, Issue 12
1 Dec 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author

 

Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Association for Respiratory Care.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection
(Your Name) has sent you a message from American Association for Respiratory Care
(Your Name) thought you would like to see the American Association for Respiratory Care web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection
Anup K Singh, Margarita Oks, Gregg Husk, Samuel P Dechario, Bushra Mina, Kanwaljit Singh, Linda Kirschenbaum, Charles M Carpati, Omar Mahmoud, Nader Ishak Gabra, Oki Ishikawa, Erica Altschultz, Varun Shah, Akhilesh Mahajan, Arun Gautam, Brian Birnbaum, Anthony C Antonacci, Suhail Raoof
Respiratory Care Dec 2021, 66 (12) 1805-1814; DOI: 10.4187/respcare.08779

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Impact of Timing of Tocilizumab Use in Hospitalized Patients With SARS-CoV-2 Infection
Anup K Singh, Margarita Oks, Gregg Husk, Samuel P Dechario, Bushra Mina, Kanwaljit Singh, Linda Kirschenbaum, Charles M Carpati, Omar Mahmoud, Nader Ishak Gabra, Oki Ishikawa, Erica Altschultz, Varun Shah, Akhilesh Mahajan, Arun Gautam, Brian Birnbaum, Anthony C Antonacci, Suhail Raoof
Respiratory Care Dec 2021, 66 (12) 1805-1814; DOI: 10.4187/respcare.08779
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Methods
    • Results
    • Discussion
    • Conclusions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Related Articles

Cited By...

Keywords

  • tocilizumab
  • COVID19 mortality
  • interlukin-6

Info For

  • Subscribers
  • Institutions
  • Advertisers

About Us

  • About the Journal
  • Editorial Board
  • Reprints/Permissions

AARC

  • Membership
  • Meetings
  • Clinical Practice Guidelines

More

  • Contact Us
  • RSS
American Association for Respiratory Care

Print ISSN: 0020-1324        Online ISSN: 1943-3654

© Daedalus Enterprises, Inc.

Powered by HighWire